


下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Hotline:400-820-3792Inhibitors ? ScreeningLibraries ? Proteinswww.MedChemESalidroside(Standard)Cat.No.:HY-N0109RCASNo.:10338-51-9Synonyms:Rhodioloside(Standard)分子式:C??H??O?分子量:300.31作用靶點(diǎn):ProlylEndopeptidase(PREP);mTOR;Apoptosis作用通路:MetabolicEnzyme/Protease;PI3K/Akt/mTOR;Apoptosis儲(chǔ)存方式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.溶解性數(shù)據(jù)體外實(shí)驗(yàn)H2O:≥100mg/mL(332.99mM)DMSO:100mg/mL(332.99mM;Needultrasonic)*"≥"meanssoluble,butsaturationunknown.MassSolvent1mg5mg10mgConcentration制備儲(chǔ)備液1mM3.3299mL16.6495mL33.2989mL5mM0.6660mL3.3299mL6.6598mL10mM0.3330mL1.6649mL3.3299mLBIOLOGICALACTIVITY生物活性Salidroside(Standard)是Salidroside的分析標(biāo)準(zhǔn)品。本產(chǎn)品用于研究及分析應(yīng)用。Salidroside(Rhodioloside)是一種脯氨酰內(nèi)肽酶(prolylendopeptidase)抑制劑。Salidroside可通過(guò)激活mTOR信號(hào)緩解腫瘤惡病質(zhì)小鼠模型中的惡病質(zhì)癥狀。Salidroside還能通過(guò)增強(qiáng)PINK1/Parkin介導(dǎo)的線粒體自噬來(lái)保護(hù)多巴胺能神經(jīng)元。IC50&TargetProlylendopeptidase[1]mTOR[2]1/3 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemE體外研究Salidroside(100μM)inhibitsprolylendopeptidase(PEP)activity(10.6±1.9%).Prolylendopeptidaseisanenzymethatplaysaroleinthemetabolismofproline-containingneuropeptidasewhichisrecognizedtobeinvolvedinlearningandmemory[1].Salidroside,oneofthemajorphenylpropanoidglycosidesfoundinR.?roseaL,isconsumedalmostdailyasanutritionalsupplementinmanycountriesandhasbeenidentifiedpossessingpotentialanti-fatigueandanoxia,anti-aging,andanti-Alzheimer'sdiseaseactivities.SalidrosidecanimprovemusclenutritionviaincreasingmTOR,p-mTOR,andMyHCexpression[2].SH-SY5Ycellsareexposedto0-600?μMMPP+for12-48?handtheresultsshowthatMPP+resultsinasignificantdecreaseofcellviabilityinaconcentrationandtime-dependentmanner.Cellsarepretreatedwith25-100?μMSalidroside(Sal)for24?handthenexposedto500?μMMPP+foranadditional24?h.Salidrosideconcentration-dependentlypreventsMPP+-induceddecreaseofcellviability.AnnexinV/PIstainingisacommonmethodforthedetectionofapoptoticcell.SalidrosidesignificantlydecreasesthenumberofAnnexinV/PI-stainedcellstreatedbyMPP+whichisinaconcentration-dependentmanner.ApoptoticcellcouldalsobemorphologicallyevaluatedbyHoechststaining.InHoechststaining,apoptoticcellsarecharacterizedbyreducednuclearsize,chromatincondensation,intensefluorescence,andnuclearfragmentation.SalidrosidenotablyinhibitsMPP+-inducedincreaseofchromatincondensation,intensefluorescence,andnuclearfragmentationinSH-SY5Ycells[3].體內(nèi)研究SalidrosideisanaturalantioxidantextractedfrommedicinalfoodplantRhodiolarosea.Salidroside(100mg/kg/day)showsstrongglucoseloweringeffectondb/dbmicewhichissimilartoeffectofMetformin(200mg/kg/day)[4].Salidrosidecanbeusedtoinducetesticularinjurymodelinmice[6].客戶使用本產(chǎn)品發(fā)表的科研文獻(xiàn)ChemEngJ.1May2022,135115.Phytomedicine.2022Jan29;99:153964.FreeRadicBiolMed.2024Feb2:214:54-68.IntImmunopharmacol.2023Mar20;117:109975.FrontPharmacol.2020Nov11;11:580407.Seemorecustomervalidationsonwww.MedChemEREFERENCESWangZ,etal.SalidrosideAmelioratesFuran-InducedTesticularInflammationinRelationtotheGut-TestisAxisandIntestinalApoptosis.JAgricFoodChem.2023Nov9.LiR,etal.SalidrosideProtectsDopaminergicNeuronsbyEnhancingPINK1/Parkin-MediatedMitophagy.OxidMedCellLongev.2019Sep10;2019:9341018.FanW,etal.ProlylendopeptidaseinhibitorsfromtheundergroundpartofRhodiolasachalinensis.ChemPharmBull(Tokyo).2001Apr;49(4):396-401.JuL,etal.Salidroside,ANaturalAntioxidant,Improvesβ-CellSurvivalandFunctionviaActivatingAMPKPathway.FrontPharmacol.2017Oct18;8:749.2/3 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemEChenX,etal.SalidrosidealleviatescachexiasymptomsinmousemodelsofcancercachexiaviaactivatingmTORsignalling.JCachexiaSarcopeniaMuscle.2016May;7(2):225-32.WuL,etal.SalidrosideProtectsagainstMPP+-InducedNeuronalInjurythroughDJ-1-Nrf2AntioxidantPathway.EvidBasedComplementAlternatMed.2017;2017:5398542.Mce
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 醫(yī)院專職保安合同范本
- 煤炭貨物貸款合同范本
- 土地股權(quán)質(zhì)押合同范本
- 工程頂賬采購(gòu)合同范本
- 折價(jià)銷售客票合同范本
- 預(yù)防在心健康相伴
- 設(shè)計(jì)綜合素質(zhì)培訓(xùn)
- 靜脈藥物配制中心年終總結(jié)
- 100道高職單招職業(yè)適應(yīng)性測(cè)試知識(shí)點(diǎn)(文學(xué)常識(shí)篇)
- 皖江工學(xué)院《聲樂(lè)與視唱》2023-2024學(xué)年第二學(xué)期期末試卷
- 2024年成都香城投資集團(tuán)有限公司招聘筆試沖刺題(帶答案解析)
- 2023版《思想道德與法治》(緒論-第一章)緒論 擔(dān)當(dāng)復(fù)興大任 成就時(shí)代新人;第一章 領(lǐng)悟人生真諦 把握人生方向 第3講 創(chuàng)造有意義的人生
- 心衰的治療指南PPT2024
- mil-std-1916抽樣標(biāo)準(zhǔn)(中文版)
- 2024年LED手電筒行業(yè)技術(shù)趨勢(shì)分析
- 醫(yī)療器械經(jīng)營(yíng)與藥品經(jīng)營(yíng)的區(qū)別
- 鋼絲繩吊裝時(shí)最大允許吊裝重物對(duì)應(yīng)表
- 專題四“挺膺擔(dān)當(dāng)”主題團(tuán)課
- 設(shè)計(jì)報(bào)價(jià)單模板
- 欽州卓達(dá)生物能源有限公司年產(chǎn)1500噸木炭項(xiàng)目環(huán)境影響報(bào)告表
- DB43-T+2181-2021學(xué)校治安反恐防范要求
評(píng)論
0/150
提交評(píng)論